Showing results (111-120 of 207) with videos related to
Sort By:
Pageof 21
Primary Care Diabetes|August 25, 2014
Diabetes prevention program in a Mediterranean environment: individual or group therapy? An effectiveness evaluationR Endevelt, R Peled, A Azrad, et al.Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur|June 9, 2000
[In vitro effects of growth hormone on osteoclastic activity: clinical applications]A V Rousselle, C Damiens, J Guicheux, et al.Family Practice|March 18, 2005
Mandatory computer field for blood pressure measurement improves screeningA D Heymann, I Hoch, L Valinsky, et al.QJM : Monthly Journal of the Association of Physicians|February 26, 2008
The association between glycemic, lipids and blood pressure control among Israeli diabetic patientsA Elis, L Rosenmann, G Chodick, et al.Expert Review of Anticancer Therapy|February 10, 2007
Key roles of the OPG-RANK-RANKL system in bone oncologyM Baud'huin, L Duplomb, C Ruiz Velasco, et al.Cytokine & Growth Factor Reviews|December 2, 2008
Proteases and bone remodellingS Georges, C Ruiz Velasco, V Trichet, et al.Cytokine|January 1, 1997
Upmodulation of multinucleated cell formation in long-term human bone marrow cultures by leukaemia inhibitory factor (LIF)D Heymann, F Gouin, J Guicheux, et al.Journal of the American Medical Informatics Association : JAMIA|August 20, 2003
Countrywide computer alerts to community physicians improve potassium testing in patients receiving diureticsIsaac Hoch, Anthony D Heymann, Irena Kurman, et al.The Israel Medical Association Journal : IMAJ|February 28, 2004
Systematic Inventive Thinking: a new tool for the analysis of complex problems in medical managementAnthony D Heymann, Joseph Azuri, Ehud Kokia, et al.Biochimica Et Biophysica Acta|September 15, 2004
RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysisY Wittrant, S Théoleyre, C Chipoy, et al.Pageof 21